GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling

[1]  H. Hagberg,et al.  Brain barrier properties and cerebral blood flow in neonatal mice exposed to cerebral hypoxia-ischemia , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  E. Aronica,et al.  Phosphoinositide 3-kinases upregulate system xc(-) via eukaryotic initiation factor 2α and activating transcription factor 4 - A pathway active in glioblastomas and epilepsy. , 2014, Antioxidants & redox signaling.

[3]  C. Thornton,et al.  Mitochondria: hub of injury responses in the developing brain , 2014, The Lancet Neurology.

[4]  H. Hagberg,et al.  Time-Dependent Effects of Systemic Lipopolysaccharide Injection on Regulators of Antioxidant Defence Nrf2 and PGC-1α in the Neonatal Rat Brain , 2013, Neuroimmunomodulation.

[5]  L. Acarín,et al.  Temporal Expression of Cytokines and Signal Transducer and Activator of Transcription Factor 3 Activation after Neonatal Hypoxia/Ischemia in Mice , 2013, Developmental Neuroscience.

[6]  David J. Fleet,et al.  Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study. , 2012, Journal of Alzheimer's disease : JAD.

[7]  D. Ferriero,et al.  Involvement of the Akt/GSK-3β/CRMP-2 pathway in axonal injury after hypoxic–ischemic brain damage in neonatal rat , 2012, Neuroscience.

[8]  P. Rada,et al.  Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis , 2012, Molecular and Cellular Biology.

[9]  H. Kang,et al.  Protein Kinase C δ (PKCδ)-Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling Cascade Regulates Glycogen Synthase Kinase-3 (GSK-3) Inhibition-mediated Interleukin-10 (IL-10) Expression in Lipopolysaccharide (LPS)-induced Endotoxemia* , 2012, The Journal of Biological Chemistry.

[10]  L. Martin,et al.  Neuronal cell death in neonatal hypoxia‐ischemia , 2011, Annals of neurology.

[11]  P. Spano,et al.  Glycogen synthase kinase‐3 inhibition reduces ischemic cerebral damage, restores impaired mitochondrial biogenesis and prevents ROS production , 2011, Journal of neurochemistry.

[12]  Hsin-Yi Huang,et al.  Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades , 2010, Journal of Neuroinflammation.

[13]  B. Zhu,et al.  Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. , 2010, Free radical biology & medicine.

[14]  Eun-Mi Hur,et al.  GSK3 signalling in neural development , 2010, Nature Reviews Neuroscience.

[15]  K. Blomgren,et al.  Lithium reduces apoptosis and autophagy after neonatal hypoxia–ischemia , 2010, Cell Death and Disease.

[16]  R. Roberts,et al.  Light and Electron Microscopy Study of Glycogen Synthase Kinase-3β in the Mouse Brain , 2010, PloS one.

[17]  B. Doble,et al.  GSK-3 is a master regulator of neural progenitor homeostasis , 2009, Nature Neuroscience.

[18]  R. Jope,et al.  Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain , 2009, Journal of Neuroinflammation.

[19]  R. Jope,et al.  Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. , 2009, Cellular signalling.

[20]  Keri A. Barksdale,et al.  Unregulated mitochondrial GSK3β activity results in NADH:Ubiquinone oxidoreductase deficiency , 2008, Neurotoxicity Research.

[21]  P. Rada,et al.  Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal celldeath , 2008, Molecular and Cellular Neuroscience.

[22]  R. Jope,et al.  Differential Regulation of STAT Family Members by Glycogen Synthase Kinase-3* , 2008, Journal of Biological Chemistry.

[23]  A. I. Rojo,et al.  GSK‐3β down‐regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress , 2008 .

[24]  Changlian Zhu,et al.  Matrix Metalloproteinase-9 Gene Knock-out Protects the Immature Brain after Cerebral Hypoxia–Ischemia , 2007, The Journal of Neuroscience.

[25]  F. Groenendaal,et al.  Gender-Specific Neuroprotection by 2-Iminobiotin after Hypoxia—Ischemia in the Neonatal Rat via a Nitric Oxide Independent Pathway , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  R. Jope,et al.  The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways , 2006, Progress in Neurobiology.

[27]  A. I. Rojo,et al.  Glycogen Synthase Kinase-3β Inhibits the Xenobiotic and Antioxidant Cell Response by Direct Phosphorylation and Nuclear Exclusion of the Transcription Factor Nrf2* , 2006, Journal of Biological Chemistry.

[28]  E. Fish,et al.  Stats: multifaceted regulators of transcription. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[29]  E. Ghigo,et al.  Growth Hormone-Releasing Peptide Hexarelin Reduces Neonatal Brain Injury and Alters Akt/Glycogen Synthase Kinase-3β Phosphorylation , 2005 .

[30]  R. Jope,et al.  Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3 , 2005, Nature Immunology.

[31]  P. Salinas,et al.  Signalling in neural development: WNTS in the vertebrate nervous system: from patterning to neuronal connectivity , 2005, Nature Reviews Neuroscience.

[32]  K. Blomgren,et al.  IGF‐I neuroprotection in the immature brain after hypoxia‐ischemia, involvement of Akt and GSK3β? , 2005, The European journal of neuroscience.

[33]  T. Laessig,et al.  Glycogen Synthase Kinase-3β Phosphorylates Bax and Promotes Its Mitochondrial Localization during Neuronal Apoptosis , 2004, The Journal of Neuroscience.

[34]  J. O'Callaghan,et al.  Induction of gp130-related Cytokines and Activation of JAK2/STAT3 Pathway in Astrocytes Precedes Up-regulation of Glial Fibrillary Acidic Protein in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Neurodegeneration , 2004, Journal of Biological Chemistry.

[35]  Ling Song,et al.  Glycogen Synthase Kinase-3β (GSK3β) Binds to and Promotes the Actions of p53* , 2003, Journal of Biological Chemistry.

[36]  P. Gressens,et al.  Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice. , 2003, Brain research. Developmental brain research.

[37]  K. Blomgren,et al.  Interleukin-18 Involvement in Hypoxic–Ischemic Brain Injury , 2002, The Journal of Neuroscience.

[38]  Changlian Zhu,et al.  Synergistic Activation of Caspase-3 by m-Calpain after Neonatal Hypoxia-Ischemia , 2001, The Journal of Biological Chemistry.

[39]  J W Yates,et al.  Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. , 2000, Chemistry & biology.

[40]  C. Justicia,et al.  Activation of the JAK/STAT pathway following transient focal cerebral ischemia: Signaling through Jak1 and Stat3 in astrocytes , 2000, Glia.

[41]  H. Hagberg,et al.  Antenatal brain injury: aetiology and possibilities of prevention. , 2000, Seminars in neonatology : SN.

[42]  Hans Clevers,et al.  Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis , 1998, Nature.

[43]  K. Imahori,et al.  Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Woodgett,et al.  Molecular cloning and expression of glycogen synthase kinase‐3/factor A. , 1990, The EMBO journal.

[45]  H. Weng,et al.  The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain. , 2013, Journal of pharmaceutics & pharmacology.

[46]  A. I. Rojo,et al.  GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. , 2008, Journal of neurochemistry.

[47]  N. Maulik,et al.  Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. , 2006, Journal of molecular and cellular cardiology.

[48]  E. Ghigo,et al.  Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3beta phosphorylation. , 2005, Endocrinology.